TKC151390
|
MCF7 |
|
9800.0 |
nM |
CC50 |
C4194 |
|
TKC151390
|
KB |
KB (HeLa derivative); HeLa-KB; Strain KB |
36180.0 |
nM |
CC50 |
C27677 |
|
TKC151390
|
PBMC |
|
27431.0 |
nM |
IC50 |
|
|
TKC151390
|
CCRF-CEM |
CCRF/CEM; CCRFCEM; CCRF.CEM; CCRF CEM; CCRF; CEM; CEM-CCRF; CEM-CCRF (CAMR); CCRF/CEM/0; CEM/0; CEM-0; CCRF-CEM/S; GM03671; GM03671C |
69.0 |
nM |
EC50 |
C7953 |
Orphanet_99861 |
TKC151390
|
ADR5000 cell line |
CCRF ADR5000; CCRF-ADR5000; CEM/ADR5000; CEM/ADR 5000; CEM-ADR5000; CEM ADR5000; ADR5000 |
100.0 |
nM |
EC50 |
C7953 |
Orphanet_99861 |
TKC151390
|
HEK293 |
|
2900.0 |
nM |
IC50 |
|
|
TKC151390
|
HepG2 |
|
6500.0 |
nM |
IC50 |
C3728 |
Orphanet_449 |
TKC151390
|
MRC5 |
MRC5; MRC 5; MRCV; MRC-V; Medical Research Council cell strain-5 |
6800.0 |
nM |
IC50 |
|
|
TKC151390
|
HeLa |
HELA; Hela; He La; He-La; HeLa-CCL2; Henrietta Lacks cells; Helacyton gartleri |
3200.0 |
nM |
IC50 |
C27677 |
|
TKC151390
|
L6 |
L-6; L-6 myoblast |
1500.0 |
nM |
IC50 |
|
|
TKC151390
|
SK-HEP1 |
SK-Hep-1; SK HEP-1; SK HEP 01; SK-Hep1; Sk-Hep1; SK Hep1; SKHEP-1; SKHEP1; SKHep1; SK_HEP1 |
10000.0 |
nM |
IC50 |
C7106 |
|
TKC151390
|
MCF-10A |
MCF 10A; MCF.10A; MCF10A; MCF10-A; MCF10a; MCF-10 Attached; Michigan Cancer Foundation-10A |
21000.0 |
nM |
IC50 |
|
|
TKC151390
|
BT-474 |
Bt-474; BT474 |
7800.0 |
nM |
IC50 |
C4194 |
|
TKC151390
|
MDA-MB-231 |
MDA_MB_231; MDA-MB 231; MDA.MB.231; MDA MB 231; MDA MB231; MDA Mb231; MDA-MB231; MDAMB-231; MDAMB231; MDA-231; MDA-231P; MDA231; MDA231-BRE; MB231; MD Anderson-Metastatic Breast-231 |
10040.0 |
nM |
EC50 |
C5214 |
|
TKC151390
|
HL-60 |
HL 60; HL.60 HL60; Human Leukemia-60 |
2000.0 |
nM |
IC50 |
C9154 |
Orphanet_519 |
TKC151390
|
MCF7 |
|
38710.0 |
nM |
IC50 |
C4194 |
|
TKC151390
|
K562/Adr |
K562/adr; K-562adr; K562adr; K562/ADM |
78.0 |
% |
Activity |
C9110 |
Orphanet_521 |
TKC151390
|
K562 |
K562; K.562; K 562; KO; GM05372; GM05372E |
5999.0 |
nM |
IC50 |
C9110 |
Orphanet_521 |
TKC151390
|
HUVEC |
HUV-EC-C; HUVEC |
1092.0 |
nM |
IC50 |
|
|
TKC151390
|
A549 |
|
15921.0 |
nM |
IC50 |
C3512 |
|
TKC151390
|
T47D |
|
2220.0 |
nM |
EC50 |
C4194 |
|
TKC151390
|
MDA-MB-361 |
MDA-MB 361; MDA MB 361; MDA-MB361; MDAMB361; MDA-361; MDA361; MB361; MD Anderson-Metastatic Breast-361 |
2270.0 |
nM |
EC50 |
C5214 |
|
TKC151390
|
C-33-A |
C33A; C33a; C33-A; C-33-A; C-33A; C33 |
1830.0 |
nM |
EC50 |
C180839 |
Orphanet_213767 |
TKC151390
|
L02 |
L02; LO2; HL-7702; HL7702; Liver-02; Human Liver-7702 |
72170.0 |
nM |
IC50 |
C27677 |
|
TKC151390
|
KB |
KB (HeLa derivative); HeLa-KB; Strain KB |
78500.0 |
nM |
IC50 |
C27677 |
|
TKC151390
|
Y79 |
Y79; GM01232; GM01232E |
80.0 |
% |
Activity |
C7541 |
Orphanet_790 |
TKC151390
|
H22 |
Hepatoma-22; Hepatoma 22 |
49.0 |
% |
TGI |
C38756 |
|
TKC151390
|
HCT-116 |
HCT-116; HCT.116; HCT_116; HCT116; HCT116wt; CoCL2 |
890.0 |
nM |
IC50 |
C4910 |
|
TKC151390
|
WM 266-4 |
WM-266-4; WM 266-4; WM-2664; WM2664; WM 2664; WM266; WM-266-mel; WM266mel; WC00097 |
8460.0 |
nM |
IC50 |
C3224 |
|